The correlation of plasma protein binding and molecular properties of selected antifungal drugs
Main Article Content
Abstract
Downloads
Metrics
Article Details
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution license 4.0 that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
References
R. J. Perfect, Nat. Rev. Drug Discov. 16 (2017) 603 (https://doi:10.1038/nrd.2017.46)
www. pharmafactz.com,https://pharmafactz.com/medicinal–chemistry–of–antifungal–drugs/ (date accessed 19.09.2019)
J. E. Nett, D. R. Andes, Infect. Dis. Clin. North Am. 30 (2016) 51 (https://doi.org/10.1016/j.idc.2015.10.012)
M. A. Ghannoum, L.B. Rice, Clin. Microbiol. Rev. 12 (1999) 501 (https://doi:10.1128/CMR.12.4.501)
R. Bellmann, Curr. Clin. Pharmacol. 2 (2007) 37 (https://doi.org/10.2174/157488407779422311)
M. Schäfer–Korting, H. C. Korting, F. Amann, R. Peuser, A. Lukacs, Antimicrob. Agents. Chemother. 35 (1991) 2053 (https://doi:10.1128/AAC.35.10.2053)
H. J. Schmitt, J. Andrade, F. Edwards, Y. Niki, E. Bernard, D. Armstrong, Eur. J. Clin. Microbiol. Infect. Dis. 9) (1990) 832 (https://doi.org/10.1007/BF01967386)
N. S. Ryder, L. Frank, J. Med. Vet. Mycol. 30 (1992) 451 (https://doi.org/10.1080/02681219280000611)
D. Gonzalez, S. Schmidt, H. Derendorf, Clin. Microbiol. Rev. 26 (2013) 274 (https://doi.org/10.1128/CMR.00092–12)
M. Schäfer–Korting M. H. C. Korting, W. Rittler, W. Obermüller, Infection 23 (1995) 292 (https://doi.org/10.1007/BF01716289)
J. Kujawski, H. Popielarska, A. Myka, B. Drabinska, M. Bernard, CMST 18 (2012) 81 (https://doi.org/10.12921/cmst.2012.18.02.81–88)
T. L. Lemke, D. A. Williams, The Foye's Principles of Medicinal Chemistry, 7th ed., Lippincott Williams & Wilkins, Philadelphia, PA, 2013 (ISBN-13: 978-1-6091-3345-0)
A. C. Moffat, M. D. Osselton, B. Widdop, Clarkes Analysis of Drugs and Poisons, 4th ed., Pharmaceutical Press, London, 2011 (ISBN 978-0-8536-9711-4)
www.drugbank.ca, https://www.drugbank.ca/interax/multi_search (date accessed 19.09.2019)
www.molinspiration.com, https://www.molinspiration.com/cgi-bin/properties (date accessed 19.09.2019)
www.vcclab.org, http://www.vcclab.org/lab/alogps/ (date accessed 19.09.2019)
Y. H. Zhao, J. Le, M. H. Abraham, A. Hersey, P. J. Eddershaw, C. N. Luscombe, D. Boutina, G. Beck, B. Sherbone, I. Cooper, J. A. Platts, J. Pharm. Sci. 90 (2001) 749 (https://doi.org/10.1002/jps.1031)
Y. H. Zhao, M. H. Abraham, J. Le, A. Hersey, C. N. Luscombe, G. Beck, B. Sherborne, I. Cooper, Pharm. Res. 19 (2002) 1446 (https://doi.org/10.1023/A:1020444330011)
R. Mannhold, G. I. Poda, I. V. Tetko, J. Pharm. Sci. 98 (2009) 861 (https://doi.org/10.1002/jps.21494 )
R. Estrada-Tejedor, N. Sabaté, F. Broto, S. Nonell, Afinidad 70 (2013) 250 (https://www.raco.cat/index.php/afinidad/article/view/273741/361891)
A.G. Asuero, A. Sayago, A.G. Gonzalez, Crit. Rev. Anal. Chem. 36 (2006) 41 (https://doi.org/10.1080/10408340500526766)
E. H. Kerns, L. Di, Drug-like Properties: Concepts, Structure Design and Methods: from ADME to Toxicity Optimization. Elsevier, San Diego, CA, 2008 (ISBN: 978-0-1236-
-9520-8).